| Literature DB >> 33806230 |
Hairong Zhang1, Jiabin Zou1, Xiaoxue Yan1, Junlong Chen1, Xiujiao Cao1, Jialing Wu1, Yinghui Liu1, Tingting Wang1.
Abstract
class="Chemical">Macrolides are a significant family of natural products with diverse structures <class="Gene">span class="Chemical">and bioactivities. Considerable effort has been made in recent decades to isolate additional macrolides and characterize their chemical and bioactive properties. The majority of macrolides are obtained from marine organisms, including sponges, marine microorganisms and zooplankton, cnidarians, mollusks, red algae, bryozoans, and tunicates. Sponges, fungi and dinoflagellates are the main producers of macrolides. Marine macrolides possess a wide range of bioactive properties including cytotoxic, antibacterial, antifungal, antimitotic, antiviral, and other activities. Cytotoxicity is their most significant property, highlighting that marine macrolides still encompass many potential antitumor drug leads. This extensive review details the chemical and biological diversity of 505 macrolides derived from marine organisms which have been reported from 1990 to 2020.Entities:
Keywords: biological diversity; chemical diversity; cytotoxicity; macrolides; marine organisms
Year: 2021 PMID: 33806230 PMCID: PMC8066444 DOI: 10.3390/md19040180
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The percentage of macrolides from diverse marine organisms.
Figure 2All new macrolides by source/year, n = 505.
Biological activities of marine-derived macrolides.
| Drug Class | Compounds | Pharmacology | Activities | Ref. |
|---|---|---|---|---|
| Cytotoxic a | swinholides A–C ( | KB cells | IC50: 0.041, 0,052, 1.1 μg/mL | [ |
| miyakolide ( | P388 cells | IC50: 17.5 μg/mL | [ | |
| spongiastatin 1 ( | HL-60, NCI-116, DMS 114 et al. | GI50: 2.5–3.5 × 10−11 M | [ | |
| dictyostatin 1 ( | P388 cells | undetermined | [ | |
| superstolide B ( | KB, P388, | IC50: 0.005, 0.003, 0.039 μg/mL | [ | |
| lasonolide A ( | A-549, P388 cells | IC50: 40, 2 ng/mL | [ | |
| latrunculin S ( | P388, A549, HT29, MEL28 cells | IC50: 0.5–1.2 μg/mL, | [ | |
| leucascandrolide A ( | KB, P388 cells | undetermined | [ | |
| altohyrtins B–C ( | KB cell;L1210 cells | IC50: 0.02, 0.4; 0.3 ng/mL; | [ | |
| swinholide H ( | P388 cells | undetermined | [ | |
| neonorhalichondrin B ( | P388 cells | IC50: 0.4, 0.8, 10, 0.1 ng/mL | [ | |
| salicylihalamides A ( | NCI 60 cells | GI50: 7 ± 2 nM; 60 ± 25 nM | [ | |
| callipeltoside B ( | NSCLC-N6 cells | IC50: 15.1, 30.0 μg/mL | [ | |
| arenolide ( | HCT-116, | IC50: 21, 9.8 mM | [ | |
| 30-hydroxymycalolide A ( | L1210 cells | IC50: 0.019, 0.013, 0.015 μg/mL | [ | |
| NA ( | P388, P388dox, KB tumor cells | undetermined | [ | |
| spongidepsin ( | J774.A1, HEK-392, WEHI-164 cells | IC50: 0.56, 0.66, 0.42 μg/mL | [ | |
| dactylolide ( | L1210,SK-OV-3 cells | IC50: 3.2 μg/mL | [ | |
| neohalichondramide ( | K562 cells | LC50: 4.9 μg/mL | [ | |
| lasonolides C–E ( | A-549,PANE-1 cells | IC50: 0.13, 4.5, 0.31 μM; 0.38. 4.89, 0.57, 15.6 μM | [ | |
| leiodolides A ( | HCT-116 cells | IC50: 1.4, 3.8 μg/mL | [ | |
| tedanolide C ( | HCT-116 cells | IC50: 0.057 μg/mL | [ | |
| kabiramide F–I ( | NCI cells | undetermined | [ | |
| swinholide I ( | HCT-116 cells | IC50: 5.6, 365 nM | [ | |
| oxalatrunculin B ( | HepG2, HCT-116,1301 cells | undetermined | [ | |
| neopeltolide ( | A-549, NCI-ADR-RES, P388 cell lines | IC50: 1.2, 5.1, 0.56 μg/mL | [ | |
| phorbaside C ( | HCT-116 cells | IC50: 2 μM | [ | |
| tausalarin C ( | K562 cells | IC50: 1 μg/mL | [ | |
| enigmazole A ( | IC-2 | IC50: 0.37 μg/mL | [ | |
| callyspongiolide ( | Jurkat J16 T, Ramos B lymphocytes | IC50: 70, 60 nM | [ | |
| phormidolides B ( | A-549, HT-29, MDA-MB-231 cells | undetermined | [ | |
| poecillastrins E ( | 3Y1 cells | IC50: 6.7, 1.2, 5.0 ng/mL | [ | |
| macrosphelide M ( | HL-60 cell | IC50: 33.2 μM | [ | |
| 12,13-deoxyroridin E ( | HL-60, L1210 cells | IC50: 25, 15 μg/mL | [ | |
| myrothecines H, I ( | HepG-2 cells | IC50: 8, 0.4 μM | [ | |
| marinomycins A–D ( | 60 cell line panel | LC50: 0.005–50 μM | [ | |
| arenicolide A ( | KB cells | IC50: 30 μg/mL | [ | |
| halichoblelide B ( | P388 cell line | ED50 0.63 | [ | |
| juvenimicin C ( | Hepa 1c1c7 cells | undetermined | [ | |
| astolides A ( | K-562, Pgp-positive MDR subline K-562/4 | IC50: 1.2–1.4 μM | [ | |
| biselyngbyolide A ( | HeLa S3, HL60 cells | IC50: 0.22, 0.027 μM | [ | |
| biselyngbyolide B ( | IC50: 3.5, 0.82 μM | [ | ||
| amphidinolide E ( | L1210, L5178Y cells | undetermined | [ | |
| amphidinolide G,H ( | L1210, KB cells | IC50: 0.0054, 0.00048 μg/mL; 0.0059, 0.00052 μg/mL | [ | |
| amphidinolides O ( | L1210, KB cells | IC50: 1.7, 1.6 μg/mL; | [ | |
| amphidinolide Q ( | L1210 cells | IC50: 6.4 μg/mL | [ | |
| amphidinolides R ( | L1210, KB cells | IC50: 1.4, 4.0 μg/mL; | [ | |
| amphidinolide C3 ( | P388, L1210, KB cells | undetermined | [ | |
| amphidinolide X ( | L1210, KB cells | IC50: 0.6, 7.5 μg/mL | [ | |
| amphidinolides B6 ( | DG-75 cells | IC50: 0.02, 0.4 μg/mL | [ | |
| amphidinolide C2 ( | L1210, KB cells | IC50: 0.8, 3 μg/mL | [ | |
| caribenolide I ( | HCT-116, HCT 116/VM 46,P388 | IC50: 1.6 nM, 1.6 nM, 0.03 mg/kg | [ | |
| iriomoteolide-2a ( | DG-75, cells | IC50: 0.006, 0.03 μg/mL | [ | |
| iriomoteolide-3a ( | DG-75 cells | IC50: 0.08 μg/mL | [ | |
| iriomoteolide-4a ( | DG-75 cells | IC50: 0.8, 1.0 μg/mL | [ | |
| iriomoteolide-9a ( | HeLa cells | IC50: 15, 2 μM | [ | |
| iriomoteolide-10a ( | HeLa, DG-75, MH134 cells | IC50: 1.5, 1.2, 3.3 μM | [ | |
| iriomoteolide-12a ( | DG-75 cells | IC50: 50 μM | [ | |
| bromophycolide A ( | A2780 cells | IC50: 6.7 μM | [ | |
| bromophycolide H ( | DU4475 cell line | IC50: 3.88 μM | [ | |
| bromophycolides J–Q ( | BT-549, DU4475, MDA-MD-468 et al. | IC50: 2.1–7.2 μM | [ | |
| bromophycolide K ( | DU4475 cell line | IC50: 1.5 μM | [ | |
| bryostatin 10 ( | P388 cell line | ED50: 0.33 μg/mL | [ | |
| bryostatins 16 ( | P388 cell line | ED50: 0.0093, 0.019, 0.033 μg/mL | [ | |
| aplyronines D–H ( | HeLa S3 cells | IC50: 0.075, 0.18, 0.19, 0.12, 9.8 nM | [ | |
| dolabelide A ( | HeLa S3 cells | IC50: 6.3, 1.3 μg/mL | [ | |
| dolabelides C ( | HeLa S3 cells | IC50: 1.9, 1.5 μg/mL | [ | |
| iejimalides C ( | KB, L1210 cells | IC50: 4.7, 0.2 μg/mL; 10, 0.58 μg/mL | [ | |
| lobatamides A–F ( | NCT’S 60 cells | mean panel GI50’s 1.6 nM | [ | |
| biselides A ( | NCI-H460, MDA-MB-231 cells | IC50: 3.53, 3.72 μM; | [ | |
| palmerolide A ( | HCC-2998, RXF 393 | LC50: 18, 6.5, 6.5 μM | [ | |
| Antibacteria a | curvulone A ( | undetermined | [ | |
| thiocladospolides F–J ( |
| MIC: 4 μg/mL | [ | |
| marinomycins A–D ( | MRSA, VREF | MIC: 0.1–0.6 μM | [ | |
| 11′,12′-dehydroelaiophylin ( | MRSA, vancomycin-resistant | MIC: 1–4 μg/mL | [ | |
| anthracimycin ( | MIC: 0.031 μg/mL | [ | ||
| bromophycolides A ( | MRSA and VREF | MIC: 5.9, 5.9 μM; | [ | |
| bromophycolides P–Q ( | MRSA and VREF | MIC: 1.4, 13 μM; | [ | |
| Antifugal a | leucascandrolide A ( |
| undetermined | [ |
| neohalichondramide ( |
| 12.5 mm at 25 μg/disk | [ | |
| neopeltolide ( |
| MIC: 0.62 μg/mL | [ | |
| BK223-A ( | undetermined | [ | ||
| 15G256ɩ ( | undetermined | [ | ||
| Astolides A ( | MIC: 4, 8 μg/mL | [ | ||
| bromophycolides A ( |
| MIC: 6.7, 27.7 μM | [ | |
| bromophycolides F, I ( | amphotericin B-resistant | undetermined | [ | |
| Antimitotic | halistatin 1, 2 ( | Inhibition of tubulin polymerization | undetermined | [ |
| spirastrellolide A ( | accelerating the entry of cells into mitosis | IC50: 100 ng/mL | [ | |
| Antiviral | bromophycolides A ( | HIV strains 96USHIPS7 and UG/92/029 inhibition | IC50: 9.1,9.8 μg/mL | [ |
| Antiplasmodial | kabiramide L ( | Against | IC50: 2.6 μM | [ |
| Antiparasite | bromophycolides R–U ( | Against | IC50: 0.9–8.4 μM | [ |
| VCAM b inhibition | halichlorine ( | Inhibition to VCAM-1 | IC50: 7 μg/mL | [ |
| Prevent fertilization | exiguolide ( | Inhibited fertilization of sea urchin gametes | IC50: 21 μM | [ |
| NFκB inhibition | fijiolides A ( | Reducing TNF-α-inducing NFκB activation | IC50: 0.57 μM | [ |
| Prevent fertilization | oscillariolide ( | Inhibited fertilization of echinoderm eggs | IC50: 0.5 μg/mL | [ |
| Molluscicidal activity | cyanolide A ( | Against the snail vector | LC50: 1.2 μM | [ |
| Vasoconstrict-ors | zooxanthellatoxins A ( | undetermined | [ | |
| Fast-acting toxin | prorocentrolide B ( | Rapid toxic response in the mouse bioassay | undetermined | [ |
| symbiodinolide ( | Voltage-dependent N-type Ca2+ channel-opening activity | IC50: 7 nM | [ | |
| acuminolide A ( | IC50: 10−6 M | [ | ||
| Prevent fertilizatoin | haterumalide B ( | Inhibited fertilization of sea urchin eggs | IC50: 0.01 μg/mL | [ |
a In the pharmacology column, cytotoxic, antibacteria and antifungal parts present species to which the compounds show inhibition bioactivities. b Vascular cell adhesion molecule.